There has been countless news and updates involving COVID-19 during the last several months of the pandemic. Here, CURE® looks back at some of the information regarding the virus and its connection to cancer that patients may have missed.
- With the multiple COVID-19 vaccines authorized by the Food and Drug Administration, one cancer survivor weighs the pros and cons of receiving a vaccine and what more information is needed. READ MORE.
- In an episode of the “CURE Talks Cancer” podcast, a teenager who was diagnosed with Hodgkin lymphoma at the start of the COVID-19 pandemic discusses her cancer journey and what it was like to receive treatment during the pandemic. LISTEN HERE.
- Nearly one in five patients with cancer reported that they were less likely to enroll in a clinical trial due to fears of COVID-19 exposure. READ MORE.
- In an interview with CURE®, an expert explains the importance of clinical trials during the COVID-19 pandemic and how clinicians must find a way to help ease patient anxiety as they return to the clinic. WATCH HERE.
- If a patient with cancer is no longer receiving active treatment and there are no signs of active disease, experts from The University of Texas MD Anderson Cancer Center suggest they should have a good response to the COVID-19 vaccine, however, direct data on this is not yet available. READ MORE.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.